Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients

European Journal of Immunology

Volumn 34, Issue 8, 2004, Pages 2138-2148

  Markel, Gal ^a   Achdout, Hagit ^a   Katz, Gil ^a   Ling, Khoon Lin ^b   Salio, Mariolina ^b   Gruda, Raizy ^a   Gazit, Roi ^a   Mizrahi, Sa'ar ^a   Hanna, Jacob ^a   Gonen Gross, Tsufit ^a   Arnon, Tal I ^a   Lieberman, Niva ^a   Stren, Noam ^a   Nachmias, Boaz ^a   Blumberg, Richard S ^c   Steuer, Guy ^d   Blau, Hanna ^e   Cerundolo, Vincenzo ^b   Mussaffi, Huda ^e   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ASSAF HAROFEH MEDICAL CENTER   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

CEACAM1; Human; MHC; NK cells; TAP2

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CARRIER PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; METALLOPROTEINASE; TAP2 PROTEIN; UNCLASSIFIED DRUG; ABC TRANSPORTER; CD66 ANTIGENS; CELL ADHESION MOLECULE; DIFFERENTIATION ANTIGEN; HLA ANTIGEN CLASS 1; LEUKOCYTE ANTIGEN; TAP2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CASE REPORT; CELL INTERACTION; CLINICAL FEATURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; PROTEIN INTERACTION; SCHOOL CHILD; SIBLING; SIGNAL TRANSDUCTION; SOLUBILITY; BLOOD; GENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PEDIGREE; PHYSIOLOGY;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ATP-BINDING CASSETTE TRANSPORTERS; CELL ADHESION MOLECULES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; METALLOPROTEASES; PEDIGREE;

EID: 4444252225     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425021     Document Type: Article

References (49)

1. Mandelboim, O., Malik, P., Davis, D. M., Chang, H. J., Boyson, J. E. and Strominger, J. L., Human CD16 as a lysis receptor mediating direct natural killer (NK) cell cytotoxicity. Proc. Natl. Acad. Sci. USA 1999. 96: 5640-5644.
2. Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., Bottino, C., Moretta, L. and Moretta, A., Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 1999. 190: 1505-1516.
3. Cantoni, C., Bottino, C., Vitale, M., Pessino, A., Augugliaro, R., Malaspina, A., Parolini, S., Moretta, L., Moretta, A. and Biassoni, R., NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 1999. 189: 787-796.
4. Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, A., Biassoni, R. and Moretta, L., Molecular cloning of NKp46: novel member of the immunoglobulin superfamily involved in triggering of natural cytotocxicity. J. Exp. Med. 1998. 188: 953-960.
5. Wu, J., Song, Y., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L. and Phillips, J. H., An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999. 285: 730-732.
6. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L. and Spies, T., Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999. 285: 727-729.
7. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W. and Porgador, A., Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001. 409: 1055-1060.
8. Arnon, T. I, Lev, M., Katz, G., Chernobrov, Y., Porgador, A. and Mandelboim, O., Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur. J. Immunol. 2001. 9: 2680-2689.
9. Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A., Bloushtain, N., Lev, M., Joseph, A., Kedar, E., Porgador, A. and Mandelboim, O., The mechanisms controlling the recognition of tumor and virus infected cells by NKp46. Blood 2003. 103: 664-672
10. Long, E. O., Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999. 17: 875-904.
11. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. and Moretta, L., Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 1996. 14: 619-648.
12. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
13. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M. and Lopez-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
14. Ljunggren, H. G. and Karre, K., In search of the 'missing self': MHC molecules and NK recognition. Immunol. Today 1990. 11: 237-244.
15. Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., Biassoni, R., Moretta, L. and Morreta, A., Molecular and functional characterization of Irp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur. J. Immunol. 1999. 29: 3148-3158.
16. Falco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L. and Morreta, A., Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 1999. 190: 793-801.
17. Markel, G., Lieberman, N., Katz, G., Arnon, T. I., Lotem, M., Drize, O., Blumberg, R. S., Bar-Haim, E., Mader, R., Eisenbach, L. and Mandelboim, O., CD66a interactions between human melanoma and NK cells: a novel class I MHC independent inhibitory mechanism of cytotoxicity. J. Immunol. 2002. 168: 2803-2810.
18. Thies, A., Moll, I., Berger, J., Wagener, C., Brummer, J., Schulze, H. J., Brunner, G. and Schumacher, U., CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease. J. Clin. Oncol. 2002. 20: 2530-2536.
19. Markel, G., Wolf, D., Hanna, J., Gazit, R., Goldman-Wohl, D., Lavy, Y., Yagel, S. and Mandelboim, O., Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 2002. 110: 943-953.
20. Markel, G., Mussaffi, H., Ling, K. L., Salio, M., Gadola, S., Steuer, G., Blau, H., Achdout, H., De Miguel, M., Gonen-Gross, T., Hanna, J., Arnon, T. I., Qimron, U., Volovitz, I., Eisenbach, L., Blumberg, R. S., Porgador, A., Cerundolo, V. and Mandelboim, O., The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood 2004. 103: 1770-1778.
21. Svenberg, T., Hammarstrom, S., Andersson, G., Johansson, C., Samuelson, K. and Wahren, B., Serum level of biliary glycoprotein I, a determinant of cholestasis, of similar use as gammaglutamyltranspeptidase. Scand. J. Gastroenterol. 1981. 16: 817-824.
22. Draberova, L., Cerna, H., Brodska, H., Boubelik, M., Watt, S. M., Stanners, C. P. and Draber, P., Soluble isoforms of CEACAM1 containing the A2 domain: increased serum levels in patients with obstructive jaundice and differences in 3-fucosyl-N-acetyl-lactosamine moiety. Immunology 2000. 101: 279-287.
23. Kondo, Y., Hinoda, Y., Akashi, H., Sakamoto, H., Itoh, F., Hirata, K., Kuroki, M. and Imai, K., Measurement of circulating biliary glycoprotein (CD66a) in liver diseases. J. Gastroenterol. 2001. 36: 470-475.
24. de la Salle, H., Hanau, D., Fricker, D., Urlacher, A., Kelly, A., Salamero, J., Powis, S. H., Donato, L., Bausinger, H. and Laforet, M., Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994. 265: 237-241.
25. Moins-Teisserenc, H. T, Gadola, S. D., Cella, M., Dunbar, P. R., Exley, A., Blake, N., Baykal, C., Lambert, J., Bigliardi, P., Willemsen, M., Jones, M., Buechner, S., Colonna, M., Gross, W. L. and Cerundolo, V., Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules. Lancet. 1999. 6: 1598-603.
26. Gadola, S. D., Moins-Teisserenc, H. T., Trowsdale, J., Gross, W. L. and Cerundolo, V., TAP deficiency syndrome. Clin. Exp. Immunol. 2000. 121: 173-178.
27. Mandelboim, O., Rayburn, H. T., Vales-Gomez, M., Pazmany, L., Colonna, M., Borsellino, G. and Strominger, J. L., Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 1996. 184: 913-922.
28. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M. L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 1997. 7: 273-282.
29. Morales, V. M., Christ, A., Watt, S. M., Kim, H. S., Johnson, K. W., Utku, N., Texieira, A. M., Mizoguchi, A., Mizoguchi, E., Russell, G. J., Russell, S. E., Bhan, A. K., Freeman, G. J. and Blumberg, R. S., Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 1999. 163: 1363-1370.
30. Katz, G., Markel, G., Mizrahi, S., Arnon, T. I. and Mandelboim, O., Recognition of human leukocyte antigen (HLA)-Cw4 but not -Cw6 by the natural killer cell receptor KIR2DS4. J. Immunol. 2001. 166: 7260-7267.
31. Lucka, L., Sel, S., Danker, K., Horstkorte, R. and Reutter, W., Carcinoembryonic antigen-related cell-cell adhesion molecule C-CAM is greatly increased in serum and urine of rats with liver diseases. FEBS Lett. 1998. 438: 37-40.
32. Wang, X., Kumanogoh, A., Watanabe, C., Shi, W., Yoshida, K. and Kikutani, H., Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 2001. 97: 3498-504.
33. Matamoros, N., Mile, J., Llano, M., Balas, A., Vicario, J. L., Pons, J., Crespi, C., Martinez, N., Iglesias-Alzueta, J. and Lopez-Botet, M., Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency. Clin. Exp. Immunol. 2001. 125: 274-282.
34. Doedens, J. R., Mahimkar, R. M. and Black, R. A., TACE/ADAM-17 enzymatic activity is increased in response to cellular stimulation. Biochem. Biophys. Res. Commun. 2003. 308: 331-338.
35. Le Gall, S. M., Auger, R., Dreux, C. and Mauduit, P., Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. J. Biol. Chem. 2003. 278: 45255-45268.
36. DeVito-Haynes, L. D., Demaria, S., Bushkin, Y. and Burlingham, W. J., The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection. Hum. Immunol. 1998. 59: 426-434.
37. Dong, Y., Lieskovska, J., Kedrin, D., Porcelli, S., Mandelboim, O. and Bushkin, Y., Soluble noncrassical HLA generated by the metalloproteinase pathway. Hum. Immunol. 2003. 64: 802-810.
38. Watt, S. M., Teixeira, A. M., Zhou, G. Q., Doyonnas, R., Zhang, Y., Grunert, F., Blumberg, R. S., Kuroki, M., Skubitz, K. M. and Bates, P. A., Homophilic adhesion of human CEACAM1 involves N-terminal domain interactions: structural analysis of the binding site. Blood 2001. 98: 1469-1479.
39. Tan, K., Zelus, B. D., Meijers, R., Liu, J. H., Bergelson, J. M., Duke, N., Zhang, R., Joachimiak, A., Holmes, K. V. and Wang, J. H., Crystal structure of murine sCEACAM1a[1,4]: a coronavirus receptor in the CEA family. EMBO J. 2002. 21: 2076-2086.
40. Muenzner, P., Billker, O., Meyer, T. F. and Naumann, M., Nuclear factor-kappa B directs carcinoembryonic antigen-related cellular adhesion molecule 1 receptor expression in Neisseria gonorrhoeae-infected epithelial cells. J. Biol. Chem. 2002. 277: 7438-7446.
41. Huang, J., Hardy, J. D., Sun, Y. and Shively, J. E., Essential role of biliary glycoprotein (CD66a) in morphogenesis of the human mammary epithelial cell line MCF10F. J. Cell Sci. 1999. 112: 4193-4205.
42. Hauck, C. R., Meyer, T. F., Lang, F. and Gulbins, E., CD66-mediated phagocytosis of Opa52 Neisseria gonorrhoeae requires a Src-like tyrosine kinase- and Rac1-dependent signalling pathway. EMBO J. 1998. 17: 443-454.
43. Izzi, L., Turbide, C., Houde, C., Kunath, T. and Beauchemin, N., cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 1999. 18: 5563-5572.
44. Skubitz, K. M., Campbell, K. D., Ahmed, K. and Skubitz, A. P., CD66 family members are associated with tyrosine kinase activity in human neutrophils. J. Immunol. 1995. 155: 5382-5390.
45. Fournes, B., Sadekova, S., Turbide, C., Letourneau, S. and Beauchemin, N., The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity. Oncogene 2001. 20: 219-230.
46. Budt, M., Michely, B., Muller, M. M., Reutter, W. and Lucka, L., Secreted CEACAM1 splice variants in rat cell lines and in vivo in rat serum. Biochem. Biophys. Res. Commun. 2002. 292: 749-755.
47. Kambayashi, T., Michaelsson, J., Fahlen, L., Chambers, B. J., Sentman, C. L., Karre, K. and Ljunggren, H. G., Purified MHC class I molecules inhibit activated NK cells in a cell-free system in vitro. Eur. J. Immunol. 2001. 31: 869-875.
48. Gonen-Gross, T., Achdout, H., Gazit, R., Hanna, J., Mizrahi, S., Markel, G., Goldman-Wohl, D., Yagel, S., Horejsi, V., Levy, O., Baniyash, M. and Mandelboim, O., Complexes of HLA-G protein on the cell surface are important for leukocyte Ig-like receptor-1 function. J. Immunol. 2003. 171: 1343-1351.
49. Achdout, H., Arnon, T. I., Markel, G., Gonen-Gross, T., Katz, G., Lieberman, N., Gazit, R., Joseph, A., Kedar, E. and Mandelboim, O., Enhanced recognition of human NK receptors after influenza virus infection. J. Immunol. 2003. 171: 915-923.